✦ LIBER ✦

Administration of slowly released recombinant interleukin 2 Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cells

✍ Scribed by Takashi Nishimura; Yasushi Uchiyama; Hideki Yagi; Yoshiyuki Hashimoto

Book ID: 118900184
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 478 KB
Volume: 91
Category: Article
ISSN: 0022-1759
DOI: 10.1016/0022-1759(86)90097-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Augmentation of the therapeutic efficacy

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

✍ Takashi Nishimura; Yuji Togashi; Makiko Goto; Hideki Yagi; Yasushi Uchiyama; Yos 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 805 KB

Homing of radiolabelled recombinant inte

Homing of radiolabelled recombinant interleukin-2 activated natural killer cells and their efficacy in adoptive immunotherapy against murine fibrosarcoma

✍ Anuradha Rai; Ashim K. Chakravarty 📂 Article 📅 2007 🏛 Indian Academy of Sciences 🌐 English ⚖ 609 KB

Evaluation of natural killer and lymphok

Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells

✍ J. Walewski; E. Paietta; J. Dutcher; P. H. Wiernik 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 489 KB

The augmentation of lymphokine-activated

The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2

✍ C. R. D. Carter; B. W. Hancock; R. C. Rees 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 925 KB

Fluctuations of Plasma β2-Microglobulin,

Fluctuations of Plasma β2-Microglobulin, Soluble Interleukin 2 Receptor and Interferon-Gamma Concentrations after Adoptive Immunotherapy with High-Dose Interleukin 2 and Lymphokine-Activated Killer Cells

✍ Giannella, G.; Pelosi-Testa, E.; Carlini, P.; Habetswallner, D.; Montesoro, E.; 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 565 KB

Lack of correlation between peripheral b

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t